EarningsQ4 2024 Earnings Report

Altimmune (ALT1) Q4 2024 Earnings Report

0 Followers

MX:ALT1 Q4 2024 EPS Results

Actual EPS-$5.97

Consensus EPS-$6.01

Beat/MissBeat by +$0.04

One Year Ago EPS-$9.77

Actual Revenue$90.48K

Expected Revenue$0.00

Beat/MissBeat by +$90.48K

YoY Revenue Growth-86.49%

QuarterQ4 2024

Date02/27/2025

TimeBefore Open

Conference CallThursday, February 27, 2025

MX:ALT1 Upcoming Earnings

Altimmune's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

MX:ALT1 Q4 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-2.39 / -	-3.8	―
Aug 12, 2026	2026 (Q2)	-2.50 / -2.17	-4.886	55.56% (+2.71)
May 13, 2026	2026 (Q1)	-4.38 / -3.26	-4.705	30.77% (+1.45)
Mar 05, 2026	2025 (Q4)	-4.31 / -4.89	-5.971	18.18% (+1.09)
Nov 06, 2025	2025 (Q3)	-4.92 / -3.80	-5.79	34.38% (+1.99)
Aug 12, 2025	2025 (Q2)	-6.08 / -4.89	-6.333	22.86% (+1.45)
May 13, 2025	2025 (Q1)	-6.37 / -4.70	-6.152	23.53% (+1.45)
Feb 27, 2025	2024 (Q4)	-6.01 / -5.97	-9.771	38.89% (+3.80)
Nov 12, 2024	2024 (Q3)	-6.46 / -5.79	-7.057	17.95% (+1.27)
Aug 08, 2024	2024 (Q2)	-6.32 / -6.33	-5.79	-9.37% (-0.54)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed